Georgia Institute of Technology

The Georgia Institute of Technology today announced the creation of the Parker H. Petit Center for AI-Driven Health Innovation, a new research center that will use artificial intelligence (AI) to help predict, treat, and prevent disease.

The Petit Center is made possible by a transformational commitment from technology entrepreneur, philanthropist, and Georgia Tech alumnus Parker H. "Pete" Petit.

Since 1980, Petit has provided significant philanthropic support across campus, including the naming of the Parker H. Petit Institute for Bioengineering and Bioscience (IBB), one of Georgia Tech’s 11 Interdisciplinary Research Institutes. IBB is an interdisciplinary hub for transforming biological discovery into real-world health impact, bringing together engineers, scientists, and clinicians to accelerate innovations in diagnostics, therapeutics, medical devices, and biomanufacturing. With more than 300 interdisciplinary faculty researchers, 13 research centers, and 1,300 trainees making unprecedented discoveries and generating innovative technologies, IBB is a catalyst for innovative bioengineering and bioscience research.

The success of IBB led Petit to make his latest investment, which will build on Georgia Tech’s broader commitment to medical innovation: applying engineering, computing, AI, biosciences, and systems thinking to health challenges that require more than any one field can solve. The Petit Center’s work will strengthen the tools, partnerships, and research pathways needed to help more discoveries move from the lab toward real-world patient care.

A key goal of the Petit Center will be to use AI to build more precise models of how disease works in the body. Its first research initiative will focus on creating virtual models of human cells. Led by Jeffrey Skolnick, Regents’ Professor and Mary and Maisie Gibson Chair and GRA Eminent Scholar in Computational Systems Biology in the School of Biological Sciences, researchers will use those models to study how diseases progress and to identify treatments that may work best for individual patients.

By modeling disease at the cellular level, researchers can test ideas faster, uncover links among different diseases, and focus on therapies most likely to help patients based on their unique biology. The work could expedite the discovery of new therapies for some of the hardest-to-treat diseases, including pancreatic cancer and glioblastoma, an aggressive form of brain cancer.

“Medical innovation is one of the fastest-growing areas in Georgia Tech’s research, and Pete Petit’s commitment will help us further shape the future of medicine," said Ángel Cabrera, president of Georgia Tech. “This new research center will find new ways to harness the power of AI to accelerate critical medical discoveries and move them into clinical settings so patients can get the care they need. We’re deeply grateful for Pete's support, and we’re excited to get started.”

The Parker H. Petit Center for AI-Driven Health Innovation will operate under the Institute for Data Engineering and Science (IDEaS) and bring together researchers from across Georgia Tech to advance AI-driven approaches to human health. Researchers affiliated with the Petit Center will work across fields and with clinical and healthcare organizations to help close the gap between discovery and practical use. Over time and with additional investments, the Petit Center’s work will expand into areas such as cancer biomarker discovery, healthy aging, advanced cellular therapies, and AI-supported healthcare systems.